1-27. (canceled)
28. A mobile terminal comprising:
a display having at least one graphical user interface display region configured to display a graphical user interface and an information display region configured to display graphical information; and
a processor configured to:
detect at least one touch event occurring on the at least one graphical user interface display region of the display; and
control the display to display the graphical user interface on the at least one graphical user interface display region on which the at least one touch event was detected,
wherein the graphical user interface is separately displayed on a plurality of graphical user interface display regions when two or more touch events were simultaneously detected on the plurality of graphical user interface display regions.
29. The mobile terminal of claim 28, wherein the processor is further configured to control the display to separately display a plurality of graphical user interfaces on two opposing locations along a boundary of the display when two touch events were simultaneously detected.
30. The mobile terminal of claim 28, wherein the graphical user interface comprises a plurality of graphical control keys each configured to perform a particular function.
31. The mobile terminal of claim 29, wherein:
one of the two opposing location is along a left boundary of the display; and
the other of the two opposing locations is along a right boundary of the display.
32. The mobile terminal of claim 29, wherein:
one of the two opposing location is along a top boundary of the display; and
the other of the two opposing locations is along a bottom boundary of the display.
33. A mobile terminal comprising:
a display screen having at least one graphical user interface display region configured to display a graphical user interface and an information display region configured to display graphical information,
wherein the information display region comprises a main screen portion and a sub-screen portion,
wherein the at least one graphical user interface display region comprises a first graphical user interface region and a second graphical user interface region each configured to perform one or more control operations independently with respect to the main screen portion and the sub-screen portion, and
wherein the first graphical user interface region and the second graphical user interface region are each displayed at a different position of the display screen.
34. The mobile terminal of claim 33, wherein the graphical user interface comprises a plurality of graphical control keys each configured to perform a particular function.
35. The mobile terminal of claim 33, wherein:
the first graphical user interface region is displayed along a left boundary of the display screen; and
the second graphical user interface region is displayed along a right boundary of the display screen.
36. The mobile terminal of claim 33, wherein:
the first graphical user interface region is displayed along a top boundary of the display screen; and
the second graphical user interface region is displayed along a bottom boundary of the display screen.
37. A mobile terminal comprising:
a display having at least one graphical user interface display region configured to display a graphical user interface and an information display region configured to display graphical information;
a touch sensor configured to detect touch events occurring on the display,
a sensor configured to detect a physical orientation of the mobile terminal; and
a processor configured to:
process a touch event detected by the touch sensor on the least one graphical user interface display region of the display; and
control the display to display the graphical user interface on the at least one graphical user interface display region on which the at least one touch event was detected,
wherein a position of the graphical user interface is adjusted based on the detected physical orientation of the mobile terminal.
38. The terminal of claim 37, wherein the position of the graphical user interface is adjusted by calculating a rotational movement of the mobile terminal.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
We claim:
1. A liquid composition having improved stability comprising a pharmaceutical active, solvent to solubilize said active, and a reducing agent to improve said active stability in said composition.
2. An oral composition having improved stability comprising a pharmaceutical active, solvent to solubilize said active, and a reducing agent to improve said active stability in said composition.
3. The composition according to claim 1 wherein the reducing agent has an E0 value of greater than 0.1 19 V.
4. The composition according to claim 3 wherein the reducing agent has an E0 value from about 0.1 19 V to 0.250 V.
5. The composition according to claim 4 wherein the reducing agent is selected from the group consisting of the salts of meta bisulfite and bisulfite, including their sodium and potassium salts; dithiothreitol; thiourea; sodium thiosulphate; thioglycolic acid; terbuty hydroquinone (TBHQ); acetyl cysteine; hydroquinone and mixtures thereof.
6. The composition according to claim 5 wherein the reducing agent comprises from about 0.005% to 1.000% of the composition.
7. The composition according to claim 6 wherein the reducing agent comprises from about 0.100% to about 0.01% by weight of the composition.
8. A composition according to claim 5 comprising a pharmaceutical active in an hydrophilic, water-miscible, anhydrous solvent wherein the pharmaceutical active in its un-ionized form has a percent solubility value in the solvent at ambient temperature that is equal to or greater than 0.075% and the pharmaceutical active is in it free, un-ionized form as a monomolecular dispersion in the solvent and said water.
9. The composition according to claim 8 wherein the pharmaceutical actives have a molecular weight of less than 500 grams per mole, is capable of being ionized when in an aqueous solvent and has an octanol-water partition coefficient when in the un-ionized form of at least 100.
10. The composition according to claim 9 wherein the pharmaceutical actives are selected from the group consisting of antitussives, antihistamines, non-sedating antihistamines, decongestants, expectorants, analgesic mucolytics, antipyretic anti-inflammatory agents, local anesthetics and mixtures thereof.
11. The composition according to claim 10 wherein the concentration of pharmaceutical actives in the solvent is less than or equal to 125% of the percent solubility value of said active.
12. The composition according to claim 11 wherein the pharmaceutical active is present in the solvent at a level from about 0.075% to about 25.0% by weight of the composition.
13. The composition according to claim 12 wherein the pharmaceutical active is present in the solvent at a level from about 0.28% to 10.0%.
14. The composition according to claim 13 wherein the solvent comprises from about 60% to about 99.975% by weight of the composition.
15. The composition according to claim 14 wherein the comprises from about 70% to about 99% by weight of the composition.
16. The composition according to claim 15 wherein the solvent comprises from about 85% to about 98% by weight of the composition.
18. The composition according to claim 15 wherein the solvent is hydrophilic, water-miscible, and anhydrous selected from the group consisting propylene glycol, ethanol, poly(ethylene glycol) or PEG, propylene carbonate, diethylene glycol monoethyl ether, poloxamer, glycofurol, glycerol and mixtures thereof.
19. A method for treating respiratory illnesses using the composition of claim 2 wherein the method comprises oral administration of said composition having a total dosage volume of no more than 3.0 mls.
20. The method according to claim 19 wherein the composition is placed against any of the mucosal membranes of the mouth.